Drugs / Engerix™-B Kinder
Engerix™-B Kinder
Trials 7
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02798952 | Aug 2016 → Jul 2017 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT02052661 | Feb → Sep 2014 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT01847430 | Jul 2013 → Feb 2014 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT01333813 | Apr → Sep 2011 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00984139 | Oct 2009 → Apr 2010 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00519649 | Aug → Dec 2007 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00411697 | Dec 2006 → May 2007 | hepatitis B virus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Engerix-B Kinder | “received a single dose of Engerix-B Kinder vaccine” NCT01333813 ↗ |
| Known as | Engerix | “Subjects received a single challenge dose of Engerix™ (hepatitis-B [HBV] vaccine)” NCT00519649 ↗ |
| Known as | Engerix-B | “Previously Vaccinated in Infancy With GSK Biologicals' HBV Vaccine (Engerix™-B).” NCT00519649 ↗ |
| Known as | EngerixTM-B | “received three consecutive doses of HBV vaccine (EngerixTM-B) in infancy” NCT00519649 ↗ |
| Known as | SKF103860 | “GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine, Engerix™-B Kinder (SKF103860) Challenge Dose, in Adolescents Vaccinated With Four Doses of Infanrix™ Hexa (SB217744)...” NCT02798952 ↗ |
| Modality | Vaccine | “Hepatitis B Vaccine” NCT00411697 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT00411697 ↗ |